Advanced search

161 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ContraFect Corporation Announces Management Resignations	05/12	CI
VedaBio Unveils World Class Scientific Advisory Board	08/11	AQ
CONTRAFECT CORP : Submission of Matters to a Vote of Security Holders (form 8-K)	21/23/21	AQ
Teva Pharmaceutical Industries : FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Sol Barer	20/23/20	PU
TEVA PHARMACEUTICAL INDUSTRIES LTD : Submission of Matters to a Vote of Security Holders (form 8-K)	16/23/16	AQ
NexImmune Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates	29/23/29	AQ
Teva Announces Appointment of Richard Francis as President and CEO	21/22/21	BU
ContraFect : Submission of Matters to a Vote of Security Holders - Form 8-K	20/22/20	PU
CONTRAFECT CORP : Submission of Matters to a Vote of Security Holders (form 8-K)	20/22/20	AQ
NexImmune Announces Appointment of Dr. Leena Gandhi to its Board of Directors	10/22/10	GL
NexImmune Appoints Kristi Jones as Chief Executive Officer and Member of the Board of Directors	18/22/18	GL
NexImmune Appoints Kristi Jones as Chief Executive Officer and Member of the Board of Directors	18/22/18	GL
Red Cell Forms Zephyr AI to Revolutionize Drug Discovery and Precision Medicine	22/21/22	BU
ContraFect : Corporate Presentation	25/21/25	PU
CERECOR : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	03/21/03	AQ
Cerecor : Management Change/Compensation (Form 8-K)	21/21/21	PU
CERECOR INC. : Change in Directors or Principal Officers (form 8-K)	21/21/21	AQ
Cerecor Inc. Announces Board Changes	21/21/21	CI
Cerecor : Submission of Matters to a Vote of Security Holders (Form 8-K)	16/21/16	PU
CERECOR INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	16/21/16	AQ
CONTRAFECT CORP : Submission of Matters to a Vote of Security Holders (form 8-K)	22/21/22	AQ
CERECOR : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	13/21/13	AQ
ContraFect : Corporate Presentation	31/21/31	PU
CERECOR : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	09/21/09	AQ
Cerecor : LATEST IR PRESENTATION COMPANY OVERVIEW	02/21/02	PU
NexImmune Appoints Healthcare Innovator Grant Verstandig as New Board Member	19/21/19	GL
CERECOR : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	10/20/10	AQ
Centrexion Therapeutics Raises $40.5 Million and Adds Lilly and Exome Asset Management as New Investors	29/20/29	GL
Cerecor : Appoints Gilla Kaplan, Ph.D., to the Board of Directors	13/20/13	AQ
Cerecor : Appoints Gilla Kaplan, Ph.D., to the Board of Directors	12/20/12	AQ
Cerecor Appoints Gilla Kaplan, Ph.D., to the Board of Directors	12/20/12	GL
ContraFect : Corporate Presentation	21/20/21	PU
CERECOR INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	19/20/19	AQ
TEVA PHARMACEUTICAL INDUSTRIES LTD : Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	10/20/10	AQ
CONTRAFECT CORP : Submission of Matters to a Vote of Security Holders (form 8-K)	14/20/14	AQ
CERECOR : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	08/20/08	AQ
Cerecor Reports Q1 2020 Results and Update	07/20/07	GL
CERECOR INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	28/20/28	AQ
Cerecor Inc. Announces Executive and Board Changes	28/20/28	CI
Cerecor : Announces Changes to Board of Directors	27/20/27	AQ
Cerecor Announces Changes to Board of Directors	24/20/24	GL
BioNJ :'s 27th Annual Dinner Meeting & Innovation Celebration Honors New Jersey's Innovators and the Patients Who Inspire Them	12/20/12	PR
AEVI GENOMIC MEDICINE, INC. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	04/20/04	AQ
Aevi Genomic Medicine, Inc. Announces Resignation of Directors	04/20/04	CI
CERECOR INC. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	04/20/04	AQ
Cerecor Inc. Announces Management Changes	04/20/04	CI
Cerecor and Aevi Genomic Medicine Complete Merger	04/20/04	GL
Cerecor Inc. completed the acquisition of Aevi Genomic Medicine, Inc..	03/20/03	CI
BioNJ : Announces the 2020 Innovator Award Honorees	07/20/07	PR
NexImmune Appoints Sol Barer as Chairman of the Board of Directors	16/19/16	GL

No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW